Proxecto de investigación
PR2005_20/01
Novel comprehensive immunotherapy to specifically target the malignant clone in Sézary syndrome, an ultra-rare cancer of mature T lymphocytes
date_range
Duración do 12 de xaneiro de 2020 ao 30 de novembro de 2023
(47 meses)
